Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Name: Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Published: 2025
License: Public Domain

ECOG-ACRIN Cancer Research Group · 2025

ClinicalTrials.gov · Datasets · License: Public Domain · 2025

Open Source ↗

gastric adenocarcinoma, gastroesophageal junction adenocarcinoma, peritoneal carcinomatosis, ea2234, intraperitoneal paclitaxel, stopgap ii, stopgap i, gastric carcinomatosis, interventional, phase2, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity

Related documents